U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Occult Breast Carcinoma

MedGen UID:
1612883
•Concept ID:
C4527188
•
Neoplastic Process

Definition

Breast carcinoma presenting with isolated axillary lymphadenopathy, without clinical or mammographic evidence of breast tumor. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVOccult Breast Carcinoma

Professional guidelines

PubMed

Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis.
Macedo FI, Eid JJ, Flynn J, Jacobs MJ, Mittal VK
Ann Surg Oncol 2016 Jun;23(6):1838-44. Epub 2016 Feb 1 doi: 10.1245/s10434-016-5104-8. PMID: 26832884
Treatment outcomes of occult breast carcinoma and prognostic analyses.
Wang J, Zhang YF, Wang X, Wang J, Yang X, Gao YQ, Fang Y
Chin Med J (Engl) 2013 Aug;126(16):3026-9. PMID: 23981605
Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
Wang X, Zhao Y, Cao X
Breast J 2010 Jan-Feb;16(1):32-7. doi: 10.1111/j.1524-4741.2009.00848.x. PMID: 20465598

Recent clinical studies

Etiology

Occult disease in reduction mammoplasties and prophylactic mastectomies.
Nomikos A, Husain EA, Graham AD
Breast J 2020 Apr;26(4):691-696. Epub 2019 Aug 25 doi: 10.1111/tbj.13512. PMID: 31448509
Incidental breast carcinoma in reduction mammoplasty.
Huysmans M, Bronckaers M, Schillebeeckx C, Servaes D
Acta Chir Belg 2017 Oct;117(5):308-311. Epub 2017 Jun 13 doi: 10.1080/00015458.2017.1328767. PMID: 28610472
Treatment outcomes of occult breast carcinoma and prognostic analyses.
Wang J, Zhang YF, Wang X, Wang J, Yang X, Gao YQ, Fang Y
Chin Med J (Engl) 2013 Aug;126(16):3026-9. PMID: 23981605
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, Cardillo A, Ghisini R, Galimberti V, Veronesi P, Monti S, Luini A, Raviele PR, Mastropasqua MG, Goldhirsch A, Colleoni M
Breast Cancer Res Treat 2011 Oct;129(3):867-75. Epub 2011 Aug 6 doi: 10.1007/s10549-011-1697-6. PMID: 21822638
Occult breast carcinoma in breast reduction specimens in European women.
Goyal A, Coulson SG, Wu JM, Suvarna SK, Reed MW, Caddy CM
Breast Cancer Res Treat 2011 Aug;128(3):749-53. Epub 2011 May 28 doi: 10.1007/s10549-011-1589-9. PMID: 21625930

Diagnosis

Occult Breast Carcinoma Is More Common in Women Undergoing Breast Reduction after Contralateral Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick SE, Lam TC
Plast Reconstr Surg 2020 Aug;146(2):117e-126e. doi: 10.1097/PRS.0000000000006965. PMID: 32740565
Incidental breast carcinoma in reduction mammoplasty.
Huysmans M, Bronckaers M, Schillebeeckx C, Servaes D
Acta Chir Belg 2017 Oct;117(5):308-311. Epub 2017 Jun 13 doi: 10.1080/00015458.2017.1328767. PMID: 28610472
Treatment outcomes of occult breast carcinoma and prognostic analyses.
Wang J, Zhang YF, Wang X, Wang J, Yang X, Gao YQ, Fang Y
Chin Med J (Engl) 2013 Aug;126(16):3026-9. PMID: 23981605
Breast magnetic resonance imaging in patients with occult breast carcinoma: evaluation on feasibility and correlation with histopathological findings.
Lu H, Xu YL, Zhang SP, Lang RG, Zee CS, Liu PF, Fu L
Chin Med J (Engl) 2011 Jun;124(12):1790-5. PMID: 21740834
Occult breast carcinoma: a report of four cases and review of literature.
Misra AK, Mishra A, Agrawal G, Agarwal A, Mishra SK
Indian J Cancer 2001 Mar;38(1):49-54. PMID: 14758886

Therapy

Occult Breast Carcinoma Is More Common in Women Undergoing Breast Reduction after Contralateral Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick SE, Lam TC
Plast Reconstr Surg 2020 Aug;146(2):117e-126e. doi: 10.1097/PRS.0000000000006965. PMID: 32740565
Sentinel lymph node biopsy for risk-reducing mastectomy.
Burger A, Thurtle D, Owen S, Mannu G, Pilgrim S, Vinayagam R, Pain S
Breast J 2013 Sep-Oct;19(5):529-32. Epub 2013 Jul 19 doi: 10.1111/tbj.12157. PMID: 23865803
Clinical and pathological characteristics of occult breast cancer and review of the literature.
Altan E, Altundag K
J BUON 2011 Jul-Sep;16(3):434-6. PMID: 22006745
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, Cardillo A, Ghisini R, Galimberti V, Veronesi P, Monti S, Luini A, Raviele PR, Mastropasqua MG, Goldhirsch A, Colleoni M
Breast Cancer Res Treat 2011 Oct;129(3):867-75. Epub 2011 Aug 6 doi: 10.1007/s10549-011-1697-6. PMID: 21822638
Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography.
Ko EY, Han BK, Shin JH, Kang SS
Korean J Radiol 2007 Sep-Oct;8(5):382-9. doi: 10.3348/kjr.2007.8.5.382. PMID: 17923780Free PMC Article

Prognosis

Occult Breast Carcinoma Is More Common in Women Undergoing Breast Reduction after Contralateral Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick SE, Lam TC
Plast Reconstr Surg 2020 Aug;146(2):117e-126e. doi: 10.1097/PRS.0000000000006965. PMID: 32740565
Incidental breast carcinoma in reduction mammoplasty.
Huysmans M, Bronckaers M, Schillebeeckx C, Servaes D
Acta Chir Belg 2017 Oct;117(5):308-311. Epub 2017 Jun 13 doi: 10.1080/00015458.2017.1328767. PMID: 28610472
Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis.
Macedo FI, Eid JJ, Flynn J, Jacobs MJ, Mittal VK
Ann Surg Oncol 2016 Jun;23(6):1838-44. Epub 2016 Feb 1 doi: 10.1245/s10434-016-5104-8. PMID: 26832884
Treatment outcomes of occult breast carcinoma and prognostic analyses.
Wang J, Zhang YF, Wang X, Wang J, Yang X, Gao YQ, Fang Y
Chin Med J (Engl) 2013 Aug;126(16):3026-9. PMID: 23981605
Clinical and pathological characteristics of occult breast cancer and review of the literature.
Altan E, Altundag K
J BUON 2011 Jul-Sep;16(3):434-6. PMID: 22006745

Clinical prediction guides

Sentinel lymph node biopsy after nipple-sparing mastectomy in early postoperative period: Is it feasible?
Kara H, Arikan AE, Dülgeroğlu O, Uras C
Indian J Cancer 2023 Apr-Jun;60(2):237-241. doi: 10.4103/ijc.IJC_1175_20. PMID: 37530247
Optimal Surgical Management for Occult Breast Carcinoma: A Meta-analysis.
Macedo FI, Eid JJ, Flynn J, Jacobs MJ, Mittal VK
Ann Surg Oncol 2016 Jun;23(6):1838-44. Epub 2016 Feb 1 doi: 10.1245/s10434-016-5104-8. PMID: 26832884
Clinical and pathological characteristics of occult breast cancer and review of the literature.
Altan E, Altundag K
J BUON 2011 Jul-Sep;16(3):434-6. PMID: 22006745
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation.
Montagna E, Bagnardi V, Rotmensz N, Viale G, Cancello G, Mazza M, Cardillo A, Ghisini R, Galimberti V, Veronesi P, Monti S, Luini A, Raviele PR, Mastropasqua MG, Goldhirsch A, Colleoni M
Breast Cancer Res Treat 2011 Oct;129(3):867-75. Epub 2011 Aug 6 doi: 10.1007/s10549-011-1697-6. PMID: 21822638
Occult breast carcinoma presenting as axillary metastases.
Foroudi F, Tiver KW
Int J Radiat Oncol Biol Phys 2000 Apr 1;47(1):143-7. doi: 10.1016/s0360-3016(99)00542-8. PMID: 10758316

Recent systematic reviews

Occult Breast Carcinoma Is More Common in Women Undergoing Breast Reduction after Contralateral Cancer: A Systematic Review and Meta-Analysis.
Fitzpatrick SE, Lam TC
Plast Reconstr Surg 2020 Aug;146(2):117e-126e. doi: 10.1097/PRS.0000000000006965. PMID: 32740565

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...